Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
107 Interestingly, only an estimated 15% of the active GLP-1 reaches the portal vein before the liver, due to the rapid inactivation through DPP-IV
Other pharma players and biotech companies are knocking on the door -- and if their candidates make it successfully through clinical development and regulatory review, they could make a grand entrance
These are not equivalent levels of evidence
Method 1: ClinicalTrials.gov (Most Comprehensive) Go to ClinicalTrials.gov and click "Find a Study." In the search box, type retatrutide (or the molecule ID, LY3437943 )
The fewer samples in 2021 were mainly due to the COVID-19 pandemic in 2020, as samples that reached the laboratory were usually seized much earlier
However, retatrutide is still investigational, so its long-term cancer safety profile has not yet been fully established
US$ 27.46
US$ 24.74
US$ 24.64
US$ 27.08
US$ 26.75
